Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning

Abstract

We evaluated the dose reductions caused by markers and determined the margins of the bsPTV, which was applied to the treatment using fiducial markers, using the analysis results of prostate movements.